Patents by Inventor Carla Fiorentini

Carla Fiorentini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW USE OF CNF1
    Publication number: 20210113669
    Abstract: The present application relates to the use of bacterial CNF (Cytotoxic Necrotizing Factor) and/or DNT (dermonecrotic toxin) as active ingredients or active ingredient for the prevention and/or the treatment of malaria caused by Plasmodium falciparum, pharmaceutical compositions comprising said active ingredient(s) for said use and a method of prevention and/or treatment of malaria, comprising the administration of bacterial CNF (Cytotoxic Necrotizing Factor) and/or DNT (dermonecrotic toxin) or of a composition comprising it/them to a patient in need thereof.
    Type: Application
    Filed: July 27, 2017
    Publication date: April 22, 2021
    Applicant: ISTITUTO SUPERIORE DI SANITA
    Inventors: Carla FIORENTINI, Francesco SILVESTRINI, Stefano LOIZZO, Valeria MESSINA, Sara TRAVAGLIONE, Pietro ALANO
  • NEUROLOGICAL THERAPIES
    Publication number: 20140378658
    Abstract: Cytotoxic necrotising factor 1 (CNF1) treats dysfunctional astrocytes and is useful to treat conditions associated with astrogliosis and/or neuroinflammation.
    Type: Application
    Filed: January 21, 2013
    Publication date: December 25, 2014
    Applicant: Alma Mater Studiorum-Universita di Bologna
    Inventors: Carla Fiorentini, Stefano Loizzo, Fiorella Malchiodi-Albedi, Sara Travaglione, Roberto Rimondini, Gabriele Campana
  • Treatment of Cognitive and Learning Impairment
    Publication number: 20110212895
    Abstract: Constitutive activators of Rho GTPases are useful in treating learning an cognitive disorders.
    Type: Application
    Filed: April 4, 2006
    Publication date: September 1, 2011
    Inventors: Giovanni Diana, Carla Fiorentini